Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

KOLs

This page shows the latest KOLs news and features for those working in and with pharma, biotech and healthcare.

Taming the Monster

Taming the Monster

physicians and KOLs.

Latest news

  • Signal strength Signal strength

    Certainly, as companies seek to build reputation and trust amongst KOLs, medical affairs teams will be central to demonstrating the transparency, scientific rigour and medical accountability that should underpin every communication

  • Harnessing the unrivalled power of key opinion leaders Harnessing the unrivalled power of key opinion leaders

    Indeed, many pharma companies have been shown to wait until phase III has started before approaching KOLs. ... For example, some KOLs may be experts in clinical trial design while others might excel in public speaking.

  • Back to the future Back to the future

    For example, market access and KOL management are secondary to channel management and branding.

  • Connected Healthcare Connected Healthcare

    Despite the inexorable shift to digital, Cello's research has found that information received face-to-face from peers, key opinion leaders (KOLs), pharma sales representatives and sponsored conferences remain the

  • The changing role of the modern MSL The changing role of the modern MSL

    It will also ensure that MSLs are carefully aligned across all customer-facing teams and channels to nurture existing KOL relationships and build new customers across markets. ... Doing so provides a holistic view of the KOL so the MSL knows how to

More from news
Approximately 1 fully matching, plus 109 partially matching documents found.

Latest Intelligence

  • Developing advocacy in the pharmaceutical industry Developing advocacy in the pharmaceutical industry

    Programme types are multiple and varied, and if you have a KOL or group of KOLs in mind, it is important to match your programme with their strengths and career status. ... But if you or your company is new to a therapy area, you may wish to use KOL

  • Understanding HCPs to build a meaningful brand Understanding HCPs to build a meaningful brand

    Conversely, your existing Key Opinion Leaders (KOLs) are already trusted among their peers but might appreciate help from their peers in developing their online networks. ... Consider empowering your existing KOLs to engage online. 3. Listen and learn.

  • Accelerating diagnosis in rare disease Accelerating diagnosis in rare disease

    Companies can help raise disease awareness by engaging with key opinion leaders (KOLs) and driving impactful campaigns using a multichannel communication approach. ... Scientific meetings are a valued source of learning among HCPs as they allow for

  • Accelerating diagnosis in rare disease Accelerating diagnosis in rare disease

    Companies can help raise disease awareness by engaging with key opinion leaders (KOLs) and driving impactful campaigns using a multichannel communication approach. ... Scientific meetings are a valued source of learning among HCPs as they allow for

  • A marathon and a sprint A marathon and a sprint

    At Lucid, we did it with oncology KOLs at a European congress. ... Although the congress had over 1, 000 delegates, the experience we created targeted only the top 15 KOLs in the therapy area.

More from intelligence
Approximately 7 fully matching, plus 31 partially matching documents found.

Latest from PMHub

  • Developing advocacy in the pharmaceutical industry.

    Programme types are multiple and varied, and if you have a KOL or group of KOLs in mind, it is important to match your programme with their strengths and career status. ... But if you or your company is new to a therapy area, you may wish to use KOL

  • Hanson Zandi

    Banner ads and e-alerts. Websites and KOL webcasts. Patient education &disease awareness – on and offline.

  • 5 steps to a smart key opinion leader (KOL) strategy

    Know who to deal with. It’ s important to be selective when it comes to compiling your KOL list. ... with. Once you have this knowledge, you can be confident of building a relationship with the KOL.

  • KOL engagement: Blending accessibility with reliability

    KOL engagement: Blending accessibility with reliability. KOLs and healthcare professionals these days are much more likely to be digital natives, so KOL and HCP engagement should include a blend of visibility ... Today’ s KOLs and HCPs are much

  • The pharma rising star and what they mean for your KOL strategy

    Rising stars are the KOLs of this future. They must be considered for any effective KOL strategy. ... But what about the future? ‘ Rising stars’ are the KOLs of this future.

More from PMHub
Approximately 4 fully matching, plus 56 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Quick links

Infographics

Multimedia